CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.
about
Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency.The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.Human genetics of infectious diseases: Unique insights into immunological redundancy.Alterations of expression of inflammation/immune-related genes in the dorsal and ventral striatum of adult C57BL/6J mice following chronic oxycodone self-administration: a RNA sequencing study.Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis.
P2860
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CCR5 receptor antagonists in p ...... elopment for treatment of HIV.
@en
type
label
CCR5 receptor antagonists in p ...... elopment for treatment of HIV.
@en
prefLabel
CCR5 receptor antagonists in p ...... elopment for treatment of HIV.
@en
P2093
P2860
P1476
CCR5 receptor antagonists in p ...... elopment for treatment of HIV.
@en
P2093
Dennis C Liotta
Kyle E Giesler
Lawrence J Wilson
Michelle B Kim
Valarie M Truax
Yesim A Tahirovic
P2860
P304
P356
10.1080/13543784.2016.1254615
P407
P577
2016-10-28T00:00:00Z